Cargando…

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life

There has been a dramatic rise in mental health difficulties during the coronavirus disease 2019 (COVID-19) pandemic. While young adults have the lowest risk of hospitalization and mortality due to COVID-19, they have been identified as being at highest risk of detrimental mental health outcomes dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Graff, Lesley A, Fowler, Sharyle, Jones, Jennifer L, Benchimol, Eric I, Bitton, Alain, Huang, James Guoxian, Kuenzig, M Ellen, Kaplan, Gilaad G, Lee, Kate, Mukhtar, Mariam S, Tandon, Parul, Targownik, Laura E, Windsor, Joseph W, Bernstein, Charles N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570421/
https://www.ncbi.nlm.nih.gov/pubmed/34755039
http://dx.doi.org/10.1093/jcag/gwab031
_version_ 1784594835640942592
author Graff, Lesley A
Fowler, Sharyle
Jones, Jennifer L
Benchimol, Eric I
Bitton, Alain
Huang, James Guoxian
Kuenzig, M Ellen
Kaplan, Gilaad G
Lee, Kate
Mukhtar, Mariam S
Tandon, Parul
Targownik, Laura E
Windsor, Joseph W
Bernstein, Charles N
author_facet Graff, Lesley A
Fowler, Sharyle
Jones, Jennifer L
Benchimol, Eric I
Bitton, Alain
Huang, James Guoxian
Kuenzig, M Ellen
Kaplan, Gilaad G
Lee, Kate
Mukhtar, Mariam S
Tandon, Parul
Targownik, Laura E
Windsor, Joseph W
Bernstein, Charles N
author_sort Graff, Lesley A
collection PubMed
description There has been a dramatic rise in mental health difficulties during the coronavirus disease 2019 (COVID-19) pandemic. While young adults have the lowest risk of hospitalization and mortality due to COVID-19, they have been identified as being at highest risk of detrimental mental health outcomes during the pandemic, along with women, those with lower socioeconomic status and those with pre-existing mental health conditions. Somewhat of a crisis in mental health has emerged across the general population through the evolution of the pandemic. A national Canadian survey identified a quadrupling of those experiencing pervasive elevated anxiety symptoms early in the pandemic compared to pre-pandemic levels, and a doubling of those with pervasive elevated depressive symptoms. Independent of the pandemic, persons with inflammatory bowel disease (IBD) can face multiple challenges related to their disease, which can result in a significant psychosocial burden and psychologic distress. Anxiety and depression have been found to be more prevalent in persons with IBD. Many potential factors contribute to the increased psychologic distress and negative impacts on mental health of the COVID-19 pandemic on persons with IBD. These include the fears of contracting COVID-19 or infecting other people. Many believe that IBD or its treatments predispose them to an increased risk of COVID-19 or a worse outcome if acquired. Concerns about access to health care add to mental distress. People with IBD generally report lower quality of life (QOL) compared to community controls. Psychologic interventions, in addition to adequate disease control, have been shown to improve health-related QOL. Uncertainty is another factor associated with reduced health-related QOL. Most studies suggest that persons with IBD have suffered QOL impairment during the pandemic in comparison to the pre-pandemic period. Uncertainties brought on by the pandemic are important contributors for some of the reduction in QOL.
format Online
Article
Text
id pubmed-8570421
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-85704212021-11-08 Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life Graff, Lesley A Fowler, Sharyle Jones, Jennifer L Benchimol, Eric I Bitton, Alain Huang, James Guoxian Kuenzig, M Ellen Kaplan, Gilaad G Lee, Kate Mukhtar, Mariam S Tandon, Parul Targownik, Laura E Windsor, Joseph W Bernstein, Charles N J Can Assoc Gastroenterol Supplement Articles There has been a dramatic rise in mental health difficulties during the coronavirus disease 2019 (COVID-19) pandemic. While young adults have the lowest risk of hospitalization and mortality due to COVID-19, they have been identified as being at highest risk of detrimental mental health outcomes during the pandemic, along with women, those with lower socioeconomic status and those with pre-existing mental health conditions. Somewhat of a crisis in mental health has emerged across the general population through the evolution of the pandemic. A national Canadian survey identified a quadrupling of those experiencing pervasive elevated anxiety symptoms early in the pandemic compared to pre-pandemic levels, and a doubling of those with pervasive elevated depressive symptoms. Independent of the pandemic, persons with inflammatory bowel disease (IBD) can face multiple challenges related to their disease, which can result in a significant psychosocial burden and psychologic distress. Anxiety and depression have been found to be more prevalent in persons with IBD. Many potential factors contribute to the increased psychologic distress and negative impacts on mental health of the COVID-19 pandemic on persons with IBD. These include the fears of contracting COVID-19 or infecting other people. Many believe that IBD or its treatments predispose them to an increased risk of COVID-19 or a worse outcome if acquired. Concerns about access to health care add to mental distress. People with IBD generally report lower quality of life (QOL) compared to community controls. Psychologic interventions, in addition to adequate disease control, have been shown to improve health-related QOL. Uncertainty is another factor associated with reduced health-related QOL. Most studies suggest that persons with IBD have suffered QOL impairment during the pandemic in comparison to the pre-pandemic period. Uncertainties brought on by the pandemic are important contributors for some of the reduction in QOL. Oxford University Press 2021-11-05 /pmc/articles/PMC8570421/ /pubmed/34755039 http://dx.doi.org/10.1093/jcag/gwab031 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Canadian Association of Gastroenterology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Supplement Articles
Graff, Lesley A
Fowler, Sharyle
Jones, Jennifer L
Benchimol, Eric I
Bitton, Alain
Huang, James Guoxian
Kuenzig, M Ellen
Kaplan, Gilaad G
Lee, Kate
Mukhtar, Mariam S
Tandon, Parul
Targownik, Laura E
Windsor, Joseph W
Bernstein, Charles N
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
title Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
title_full Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
title_fullStr Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
title_full_unstemmed Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
title_short Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
title_sort crohn’s and colitis canada’s 2021 impact of covid-19 and inflammatory bowel disease in canada: mental health and quality of life
topic Supplement Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570421/
https://www.ncbi.nlm.nih.gov/pubmed/34755039
http://dx.doi.org/10.1093/jcag/gwab031
work_keys_str_mv AT grafflesleya crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife
AT fowlersharyle crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife
AT jonesjenniferl crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife
AT benchimolerici crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife
AT bittonalain crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife
AT huangjamesguoxian crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife
AT kuenzigmellen crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife
AT kaplangilaadg crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife
AT leekate crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife
AT mukhtarmariams crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife
AT tandonparul crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife
AT targowniklaurae crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife
AT windsorjosephw crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife
AT bernsteincharlesn crohnsandcolitiscanadas2021impactofcovid19andinflammatoryboweldiseaseincanadamentalhealthandqualityoflife